2nd Edition of International Conference on Cardiology and Cardiovascular Science (CVS 2027) set for March 22–24, 2027 at Village Hotel Changi, 1 Netheravon Rd, Singapore and Hybrid, represents a premier international scientific platform dedicated to cardiovascular innovation and clinical advancement. Progress in heart-related medicine is being driven by technological integration, precision-based treatment models, and advanced biomedical research. Cardiovascular Science Conference 2027 will address topics including vascular remodeling, heart rhythm regulation, ischemic pathology, and evolving surgical interventions designed for complex cardiac conditions. Expert-led contributions will highlight developments in molecular cardiology, artificial intelligence-assisted diagnostics, tissue regeneration techniques, and improved cardiac imaging systems. These advancements aim to enhance early detection, treatment accuracy, and long-term patient care strategies. The Cardiology Conference gathering fosters meaningful academic interaction, enabling participants to build research alliances, exchange clinical experiences, and explore innovative approaches to cardiovascular challenges. Such engagement strengthens scientific collaboration across international institutions. Hybrid-enabled accessibility ensures participation from diverse geographical regions, offering seamless engagement through integrated digital connectivity options. This global reach extends the scientific influence of Heart Congress beyond Singapore.